Global Regulatory Compliance
Our generics are manufactured in state-of-the-art facilities compliant with USFDA, WHO-GMP and other stringent authorities — safety, efficacy and quality at every step.

A research-driven formulations company from Hyderabad, making high-quality medicine affordable in the world's most demanding markets.
Guided by rigorous research and a deep commitment to patients, we set new standards in medicine and make quality treatments available to all.
Established in 2014 and commercial in the U.S. since 2018, Graviti built its reputation the slow way — one validated process, one clean inspection, one reliable batch at a time. In India our own brands sit in the prescriber's hand; abroad the same formulations travel as generics under partner labels. Either way, the standard behind the tablet is identical.
Who we are




1600+ people across manufacturing, quality and supply.

Billion doses a month, each one traceable to the minute it was made.
We turned challenges into achievements — securing USFDA approvals, hardening our systems and partnering with leading players. In a short time we became one of the top 10 manufacturers in the US market within the portfolio we operate in.



India has always been our foundation, and today we market our own branded generics here — our brands, our field force, our prescribers — built on the same lines and the same discipline that serve our regulated-market filings.
Trusted solutions for heart health, ensuring safety and efficacy in cardiovascular care.
View portfolioGlycaemic controlReliable treatments for effective diabetes management and a better quality of life.
View portfolioNeurology & psychiatryTreatments for neurological and psychiatric conditions where dose precision is therapy.
View portfolioEveryday careHigh-quality medications for overall well-being and everyday healthcare needs.
View portfolioFour reasons partners and prescribers keep coming back.
Our generics are manufactured in state-of-the-art facilities compliant with USFDA, WHO-GMP and other stringent authorities — safety, efficacy and quality at every step.
A broad portfolio across cardiovascular, diabetes, CNS and general health, addressing major global health challenges.
Cost-efficient manufacturing and a robust supply chain let us offer high-quality medicines at accessible prices across diverse markets.
Continuous investment in research produces bioequivalent generics that meet the highest standards of quality, stability and therapeutic effectiveness.

By prioritising social responsibility, we strive to empower communities and foster a healthier, more sustainable future.


The Graviti Foundation runs an innovative after-school programme designed to spark interest in STEM careers. With a modern, concept-driven approach to mathematics, the programme transforms how students learn, making complex ideas engaging and accessible. By connecting academic foundations with future career paths, it lifts math proficiency and inspires a lasting passion for learning.
Learn moreThrough our CSR initiative we equip young minds with the real-life skills essential for employment. The programme focuses on practical education, career guidance and hands-on training, bridging the gap between education and employability. Together, we are not just manufacturing medicines; we are building futures.
Learn moreTalk to us about supply partnerships, in-licensing and contract manufacturing — or about our own branded generics range in India.